The Heart of Healthcare

Halle Tecco, Michael Esquivel, & Steve Kraus
The Heart of Healthcare

The Heart of Healthcare podcast gets to the heart of our mission in digital health — to massively improve healthcare for all.  🏆 #1 podcast in the Top 100 Health Tech All time charts 👥 Hosted by digital health veterans Halle Tecco, Michael Esquivel, and Steve Kraus 🎙 New episode every Monday Join us for authentic and compelling conversations with thought leaders as we deconstruct underlying problems in healthcare, and identify how we can work together to solve them.

  1. The Big Healthcare Reset | Dr. Sachin Jain, President and CEO, SCAN Group & Health Plan

    -6 J

    The Big Healthcare Reset | Dr. Sachin Jain, President and CEO, SCAN Group & Health Plan

    "There's been a degree of toxic positivity in US healthcare," says Dr. Sachin Jain, CEO of SCAN Health Plan. In this episode about healthcare's need for radical change, Dr. Jain challenges industry orthodoxy and calls for a leadership revolution. From Medicare Advantage turbulence to the failures of healthcare consolidation, he offers an insider's view of what needs to change. We cover: 🔄 Why healthcare needs to move beyond "toxic positivity" and incremental improvements toward real transformation ⏰ The fundamental flaw in value-based care: measuring outcomes in one-year increments when real health improvements take decades 💰 Medicare Advantage's current challenges, including benefit cuts, market exits, and controversial star ratings 🏥 Why healthcare consolidation has failed to deliver better outcomes and may be driving clinician burnout 🏠 How SCAN's "12 angry seniors" sparked a movement to help people age at home, and why that mission remains relevant today ⚡ The need for a new generation of healthcare leaders willing to think big instead of being trained to be incrementalists 🔑 His advice for the new administration --- About our guest: Sachin H. Jain, MD, MBA is President and CEO of SCAN, where he is charged with leading the organization’s growth, diversification, and emerging efforts to reduce healthcare disparities. SCAN’s revenues top $4.3 and the organization serves 300,000 patients. Under his leadership, SCAN has grown its revenues by more than $1B. Previously, Dr. Jain was President and CEO of CareMore and Aspire Health, innovative care delivery systems with > $1.6B in revenues serving 200,000 Medicare and Medicaid patients and 2500 associates in 32 states. He pioneered the first clinical program in the world focused on social isolation. Dr. Jain is also an adjunct professor of medicine at the Stanford University School of Medicine and a contributor at Forbes. Prior to joining CareMore, Dr. Jain was global Chief Medical Information & Innovation Officer at Merck & Co. He contemporaneously served as an attending physician at the Boston VA-Boston Medical Center and a member of faculties at Harvard Medical School and Harvard Business School. From 2009-2011, Dr. Jain worked in leadership roles at the US Department of Health and Human Services, where he was senior advisor to the administrator of the Centers for Medicare & Medicaid Services (CMS). Dr. Jain was the first acting deputy director for policy and programs at the Center for Medicare and Medicaid Innovation (CMMI). He also served as special assistant to the National Coordinator for Health Information Technology. --- Thank you to medical school student Eric Shan for help preparing this episode! --- 🙏 If you're enjoying the show, we would so appreciate it if you left us a review! --- 📍 Connect with us: Heart of Healthcare website LinkedIn Twitter See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    32 min
  2. The Southwest Airlines Theory of Healthcare Transformation | Iora Health Co-Founder, Rushika Fernandopulle

    9 DÉC.

    The Southwest Airlines Theory of Healthcare Transformation | Iora Health Co-Founder, Rushika Fernandopulle

    Twenty years before value-based care became a healthcare buzzword, Rushika Fernandopulle was told he had to choose: be a doctor or join "the dark side" of business. Instead, he chose both – building Iora Health from a bootstrapped startup into a billion-dollar healthcare company. In this candid conversation, Fernandopulle reveals the unconventional journey that helped transform American healthcare, from midnight meetings in Las Vegas speakeasies to breaking every rule in the traditional medical playbook. We cover: 💡 How bootstrapping for 7 years shaped Iora Health's success 🛫 The "Southwest Airlines Theory" of healthcare transformation 💰 The midnight meeting that led to a $4M investment from Zappos' Tony Hsieh 🔄 Why the employment-insurance link needs to break for real healthcare reform 🏢 The challenges tech giants face in transforming healthcare 💪 Why refusing to take "no" for an answer is Rushika's entrepreneurial superpower -- About our guest: Rushika Fernandopulle is a practicing physician and former Chief Innovation Officer of One Medical, a leading Advanced Primary Care company based in San Francisco, CA. Before this, he was co-founder and CEO of Iora Health, was the first Executive Director of the Harvard Interfaculty Program for Health Systems Improvement, and Managing Director of the Clinical Initiatives Center at the Advisory Board Company. He is a member of the Albert Schweitzer, Ashoka, Aspen, and Salzburg Global Fellowships, and is co-author or editor of several publications. He serves on the staff at the Massachusetts General Hospital and on the faculty of Harvard Medical School. He earned his A.B., M.D., and M.P.P. from Harvard University, and completed his clinical training at the University of Pennsylvania and the Massachusetts General Hospital. --- 🙏 If you're enjoying the show, we would so appreciate it if you left us a review! --- 📍 Connect with us: Heart of Healthcare website LinkedIn Twitter See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    30 min
  3. AI 🤝 Genomics | GeneDx CEO Katherine Stueland

    25 NOV.

    AI 🤝 Genomics | GeneDx CEO Katherine Stueland

    Technology is transforming genetic testing and bringing hope to families facing rare diseases. In this episode, GeneDx (Nasdaq: WGS) CEO Katherine Stueland sits down with Steve Kraus to share how AI is being used to crack life's most complex code and speed up diagnosis from years to days. We cover: 🧬 The evolution from single-gene testing (remember BRCA?) to whole genome sequencing, and why the Supreme Court's decision to ban gene patents changed everything 🔬 How 1 in 10 Americans has a rare disease, yet the path to diagnosis traditionally takes 6-8 years 💪 How parents become "honorary PhDs" in their children's rare conditions and how this drives research forward 🤖 With only 1,500 medical geneticists nationwide, AI can help bridge the expertise gap 💰 The shifting landscape of insurance coverage and why states are starting to see the value of early genetic diagnosis 📊 How GeneDx built the world's largest rare disease database (700,000 clinical exomes and counting) and what that means for future drug development 👩‍💼 Katherine's journey from communications major to CEO, and why having more women leaders matters in healthcare --- Shortcuts: 00:00 Introduction and Overview 01:29 Advancing Diagnoses for Rare Diseases 06:33 The Evolution of Genetic Testing 10:44 The Cost and Coverage of Genetic Testing 21:55 The Role of AI in Genomics and Genetic Testing 29:43 From Communications to CEO: Katherine's Journey 35:23 Promoting Gender Equality in the C-Suite --- About our guest: Katherine Stueland has dedicated her career to revolutionizing healthcare with patient-centered business approaches. Instrumental in obtaining FDA approval for breakthroughs like the first protease inhibitor for HIV/AIDS and pioneering cancer immunotherapy, she champions the integration of genomic data for precision diagnostics in rare diseases and cancer. As President and CEO of GeneDx (Nasdaq: WGS) since June 2021, she is at the forefront of transforming healthcare through the Company’s industry-leading exome and genome testing. Previously, as Chief Commercial Officer of Invitae (NYSE: NVTA), she elevated the brand to a market cap of over $6 billion. --- 🙏 If you're enjoying the show, we would so appreciate it if you left us a review! --- 📍 Connect with us: Heart of Healthcare website LinkedIn Twitter See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

    30 min
4,9
sur 5
136 notes

À propos

The Heart of Healthcare podcast gets to the heart of our mission in digital health — to massively improve healthcare for all.  🏆 #1 podcast in the Top 100 Health Tech All time charts 👥 Hosted by digital health veterans Halle Tecco, Michael Esquivel, and Steve Kraus 🎙 New episode every Monday Join us for authentic and compelling conversations with thought leaders as we deconstruct underlying problems in healthcare, and identify how we can work together to solve them.

Vous aimeriez peut‑être aussi

Pour écouter des épisodes au contenu explicite, connectez‑vous.

Recevez les dernières actualités sur cette émission

Connectez‑vous ou inscrivez‑vous pour suivre des émissions, enregistrer des épisodes et recevoir les dernières actualités.

Choisissez un pays ou une région

Afrique, Moyen‑Orient et Inde

Asie‑Pacifique

Europe

Amérique latine et Caraïbes

États‑Unis et Canada